Clinical Study
XEN1101 Drug Study for People with Primary Generalized Tonic-Clonic Seizures
The purpose of this research is to learn more about the drug XEN1101 and see if it can help to reduce the frequency of seizures (the number of seizures in a given period of time) in adults with primary generalized tonic-clonic seizures. The University of Utah anticipates enrolling five patients in this study.
For more information contact:
Marissa Castillo
marissa.castillo@hsc.utah.edu
801-587-8393
IRB#: IRB_00159508
| PI: Amir Arain
| Department: NEUROLOGY
| Approval Date: 2023-08-16 06:00:00
Study Categories: Neurological Studies
| Specialties: Neurology
Who can participate?
Gender: All
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria:
- 18-75 years old
- Diagnosed with primary generalized tonic clonic seizures
- must be willing to take contraceptions
- keep an accurate seizure diary
- in person at University of Utah
Exclusion Criteria:
- seizure type does not fit correct diagnosis
- History of drug or alcohol abuse
- pregnant
- mental health concerns
- labs out of normal range
Will I be paid for my time?
Yes